Just 20 months ago, Tandem Hospital Partners had set up a joint venture with St. Vincent to develop a series of tiny hospitals. Today, the results are far different from what either company probably imagined.
A new study by BioCrossroads and Indiana University shows the sector’s economic impact grew about 1 percent last year, to $79 billion.
While publicly backing his company’s 2015 merger with rival health insurer Anthem, Cigna’s CEO privately expressed regret about signing on to a deal that left him with a reduced role, lawyers for Anthem said in court Monday.
The move comes at a time drug makers, especially those that make insulin, are facing withering criticism for raising prices.
The state’s largest health system said earnings from operations climbed 4 percent, but investment losses pulled down total earnings by 70 percent.
A southern Indiana hospital that's struggled financially will close this spring after a decade of operation.
Spark Therapeutics Inc. will give Roche Holding a chance to make up ground in a field where single treatments may command more than $1 million. It also snaps up an asset that rivals like Novartis might have coveted.
The Indiana Senate has approved a bill allowing felony charges if the deception involves a medical procedure, device, drug or human reproductive material.
As the online retailer has moved into new industries over the years, consumers have flocked to it and numerous traditional retailers have closed their doors, unable to compete.
Major Health Partners is providing most of the money for the project—$15 million—and the city of Shelbyville and Shelby County each are committing nearly $1.6 million.
The new fundraising arm of IU Health said it exceeded its first-year goal by more than 300 percent, allowing it to expand its grants program statewide.
For a startup that has raised an eye-popping $71 million in just three years, Outpost Medicine LLC likes to keep a low profile. The young company, which is developing drugs for urinary and gastrointestinal disorders, is headquartered in small, unmarked space at the Parkwood Crossing office complex on East 96th Street. It has issued only a […]
When the Indianapolis-based drug giant made its initial offer Dec. 20, it said it wanted to seal the deal before the J.P. Morgan Healthcare Conference, which ran Jan. 7-10 in San Francisco.
One of the three breakaway companies—ag division Corteva—has significant operations in Indianapolis. Corteva will be separately traded starting June 1.
The Bloomington-based maker of medical devices said Wednesday it would appeal the verdict of a federal jury in Indianapolis, which found the device was defectively designed. More than 4,000 patients have filed lawsuits.
The Indianapolis-based pharmaceutical giant on Wednesday tempered expectations for its earnings in 2019 after a promising cancer drug failed to pan out and the firm prepared for big acquisition.
When the $175 million hospital opens in stages over the next two weeks, patients and visitors will see a major upgrade in facilities.
For hospitals, maternity care builds relationships with young families that often last for decades. About 40 percent of women experience their first encounter with hospitals for reproductive services.
Increasingly, top researchers are questioning whether drugs such as Lantus from Sanofi, Levemir and Novolog from Novo Nordisk A/S, and Humalog from Eli Lilly and Co. are really needed for many patients.
Indiana University Health and Community Health Network have joined the national trend of posting online reviews, in a quest to win prospective patients and boost transparency.
